NCT04479696
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neoplasms, Nerve Tissue
Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.
6,284 public trials
1,281 recruiting studies
Neoplasms, Nerve Tissue trial results
NCT07089641
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +12 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT05278208
- Conditions
- Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Nationwide Children's Hospital Columbus, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT07288112
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Arizona State University-Honor Health Research Institute Scottsdale, Arizona, United States
- City of Hope Duarte, California, United States
Recruiting
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
NCT07088991
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
- Locations
-
- Research Site Arkhangelsk, Russia
- Research Site Chelyabinsk, Russia
- Research Site Grozny, Russia
- Research Site Krasnoyarsk, Russia
Recruiting
Lerapolturev (PVSRIPO) in GBM
NCT06177964
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Recruiting
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT06450041
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Comer Children's Hospital, University of Chicago Chicago, Illinois, United States
NCT07080242
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +18 more
- Locations
-
- Clearview Cancer Institute Huntsville, Alabama, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center) San Francisco, California, United States
NCT06529822
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
- Locations
-
- AdventHealth Orlando, Florida, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Ohio State University Columbus, Ohio, United States
NCT07710690
- Conditions
- Glioma, HGG, High Grade Glioma, +8 more
- Locations
-
- Huashan Hospital Affiliated with Fudan University Shanghai, China
- Zhongnan Hospital of Wuhan University Wuhan, China
- The Second Affiliated Hospital of Air Force Medical University Xi'an, China